The Drug Screening market is expected to grow from USD 7.01 billion in 2019 to USD 6.66 billion by 2025 at a CAGR of 10.81% from 2019 to 2025.
Drug screening tests support to analyze and diagnose biological samples like blood, hair, and urine and detect the presence of drugs of abuse or its metabolites in the body of patients. These tests are shown in order to ascertain if a person is or was under the influence of a drug at a certain point in time. Technological advancements in drug screening devices have allowed end-users to acquire accurate results. In emerging economies like China, rising incidences of drug abuse amongst adults as well as the teenage population have hampered employment impeding the economic situation of the country proving to be the main factor contributing to industry growth. Similarly, government bodies and not-for-profit organizations focus their efforts on funding drug screening initiatives thereby augmenting drug screening practices. Although this industry has a high growth rate, certain social and political decisions may restrict market development. For instance, political decisions such as the ban on alcohol consumptions in certain countries can have a negative impact in the near future. The global market is segregated on the basis of Sample Type as Oral Fluid, Hair, Urine, Breath, and Other Samples. Based on Products & Services the global market is segmented in Drug Screening Services and Drug Screening Products. Based on End User the global market is segmented in Pain Management Centers, Schools and Colleges, Hospitals, Individual users, Workplace, Criminal Justice Systems and Law Enforcement Agencies, and Drug Treatment Centers.
The global market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and the Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.


View Complete Report: @ https://marketreportslibrary.com/report/he0259/life-science-analytics-market
The global Drug Screening market has been segmented as below:
By Sample Type
Oral Fluid
Hair
Urine
Breath
Other Samples
By Products & Services
Drug Screening Services
Drug Screening Products
Consumables
Rapid Testing Devices
Analytical Instruments
By End-User
Pain Management Centers
Schools and Colleges
Hospitals
Individual users
Workplace
Criminal Justice Systems and Law Enforcement Agencies
Drug Treatment Centers
By Region
North America
Europe
Asia-Pacific
Rest of the World
Competitive Rivalry
Alere (US), Thermo Fisher (US), Drägerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US), and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

Request a Sample of this Report: @ https://marketreportslibrary.com/request/sample/he0225/drug-screening-market
Explore other reports from ”Healthcare” sector @ https://marketreportslibrary.com/category/healthcare

Contact Us:
SRR residency Mig-59,
7th phase Kphb colony
Near prathibha school
Hyderabad, 500072
[email protected]